Nicolai Tangen
AKO Capital
AKO Capital Portfolio 13F
Nicolai Tangen Holdings Activity
- Portfolio value:
- $4.11B≈ (+$173M≈)
- Previous value:
- $3.93B≈
- # of changes:
- 21
- New positions:
- 0
- Reported for:
- 30 Sep 2019 (Q3)
- Latest filing date:
- 06 Nov 2019
AKO Capital has disclosed a total of 21 changes to the portfolio in the (2019 Q3) SEC report(s): increased the number of shares of 11 and decreased the number of shares of 10 position(s).
What stocks did Nicolai Tangen buy in 2019 Q3?
During 2019 Q3 Nicolai Tangen has bought 11 securities out of which top 5 purchases (by % change to portfolio) were (LIN) Linde plc Ordinary Shares (added shares +35.80%), (NKE) Nike Inc (added shares +22.25%), (RTX) RTX Corp (added shares +23.44%), (ALLE) ALLEGION PLC (added shares +6.30%) and (PG) Procter & Gamble Company (added shares +16.75%).
In the 2019 Q3 report(s) the following changes have been made to the top investments: (LIN) Linde plc Ordinary Shares (added shares +35.80%), (RACE) FERRARI NV (reduced shares -14.49%), (GRFS) Grifols SA ADR (reduced shares -3.21%), (NKE) Nike Inc (added shares +22.25%) and (V) Visa Inc, CL-A (reduced shares -2.89%).
21 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Zoetis Inc
|
+151.70%
|
$124.59
|
-39.10%($75.88)
|
2.31%
|
2019 Q2
|
≈ 0.50 years
|
||||
|
|
Linde plc Ordinary Shares
|
+35.80%
|
$194.02
|
+148.89%($482.89)
|
12.59%
|
2018 Q4
|
≈ 1.00 year
|
||||
|
|
RTX Corp
|
+23.44%
|
$136.52
|
+59.87%($218.25)
|
5.12%
|
2017 Q4
|
≈ 2.00 years
|
||||
|
|
Nike Inc
|
+22.25%
|
$93.92
|
-55.64%($41.66)
|
5.57%
|
2016 Q4
|
≈ 3.00 years
|
||||
|
|
Alphabet Inc, CL-C
|
+19.37%
|
$60.95
|
+516.66%($375.86)
|
4.39%
|
2016 Q4
|
≈ 3.00 years
|
||||
|
|
Procter & Gamble Company
|
+16.75%
|
$124.38
|
+18.61%($147.53)
|
4.67%
|
2018 Q4
|
≈ 1.00 year
|
||||
|
|
Edwards Lifesciences Corp
|
+12.84%
|
$73.30
|
+21.48%($89.05)
|
3.45%
|
2018 Q2
|
≈ 1.50 years
|
||||
|
|
Ambev SA ADR
|
+7.26%
|
$4.62
|
-33.77%($3.06)
|
3.90%
|
2017 Q3
|
≈ 2.25 years
|
||||
|
|
ALLEGION PLC
|
+6.30%
|
$103.65
|
+58.72%($164.51)
|
4.74%
|
2016 Q4
|
≈ 3.00 years
|
||||
|
|
Moodys Corp
|
+2.15%
|
$204.83
|
+135.90%($483.19)
|
2.28%
|
2016 Q4
|
≈ 3.00 years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.